Privia Health (PRVA) Capital Expenditures (2020 - 2026)
Privia Health (PRVA) posted Capital Expenditures of -$494000.0 for Q2 2026, up 49.49% on a QoQ basis from -$978000.0 in Q1 2026, and up 36.75% year-over-year from -$361249.1 in Q2 2025.
Analysis
Privia Health (PRVA) Capital Expenditures (2020 - 2026) Analysis & Trends
Privia Health has reported Capital Expenditures for 7 years, with the latest figure at -$494000.0 in Q2 2026.
- On a quarterly basis, Capital Expenditures rose 36.75% year-over-year to -$494000.0 in Q2 2026; TTM through Jun 2026 was -$90000.0, a 718.18% decrease from a year earlier, with the FY2025 full-year figure at $326000.0, down 81.06% from the prior year.
- Capital Expenditures was -$494000.0 for Q2 2026 at Privia Health, up from -$978000.0 in the prior quarter.
- The five-year high for Capital Expenditures was $9.9 million in Q3 2022, with the low at -$9.1 million in Q4 2022.
- Average Capital Expenditures over 5 years is $89444.4, with a median of -$493500.0 recorded in 2023.
- The sharpest annual moves came in 2022 and 2024: Capital Expenditures jumped 198500.0% in 2022, then sank 3325.0% in 2024.
- Over 5 years, Capital Expenditures stood at -$9.1 million in 2022, then jumped by 112.9% to $1.2 million in 2023, then soared by 40.87% to $1.7 million in 2024, then surged by 61.78% to $2.7 million in 2025, then plunged by 118.49% to -$494000.0 in 2026.
- The last three Capital Expenditures figures came in at -$494000.0 (Q2 2026), -$978000.0 (Q1 2026), and $2.7 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Davita | 11.76 Bn | 12.64 Bn | 1.16 Bn | 169.82 Mn |
| 2 | RadNet | 5.80 Bn | 5.37 Bn | 88.08 Mn | 11.56 Mn |
| 3 | Concentra Group Holdings Parent | 4.40 Bn | 4.26 Bn | 192.10 Mn | 15.67 Mn |
| 4 | Privia Health | 2.61 Bn | 2.25 Bn | - | -494,000.00 |
| 5 | Pediatrix Medical | 2.20 Bn | 1.79 Bn | - | 1.38 Mn |
| 6 | Fresenius Medical Care AG | 2.11 Bn | 1.41 Bn | 1.52 Bn | - |
| 7 | Progyny | 2.01 Bn | 1.77 Bn | 89.30 Mn | 6.22 Mn |
| 8 | Surgery Partners | 1.87 Bn | 3.08 Bn | 622.10 Mn | 21.80 Mn |
| 9 | U S Physical Therapy | 1.18 Bn | 1.47 Bn | 41.94 Mn | 5.36 Mn |
| 10 | Starling Oncology | 595.78 Mn | 554.69 Mn | 27.17 Mn | 908,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -494,000.00 |
| Mar 31, 2026 | -978,000.00 |
| Dec 31, 2025 | 2.67 Mn |
| Sep 30, 2025 | -1.29 Mn |
| Jun 30, 2025 | -781,000.00 |
| Mar 31, 2025 | -275,000.00 |
| Dec 31, 2024 | 1.65 Mn |
| Sep 30, 2024 | -606,000.00 |
| Jun 30, 2024 | -645,000.00 |
| Mar 31, 2024 | 1.32 Mn |
| Dec 31, 2023 | 1.17 Mn |
| Sep 30, 2023 | 1.72 Mn |
| Jun 30, 2023 | 20,000.00 |
| Mar 31, 2023 | -493,000.00 |
| Dec 31, 2022 | -9.09 Mn |
| Sep 30, 2022 | 9.93 Mn |
| Jun 30, 2022 | -546,000.00 |
| Mar 31, 2022 | -1.68 Mn |
| Dec 31, 2021 | 5.39 Mn |
| Sep 30, 2021 | 5,000.00 |